These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 38191534)

  • 1. The magnitude and variability of neurocognitive performance in first-episode psychosis: a systematic review and meta-analysis of longitudinal studies.
    Catalan A; McCutcheon RA; Aymerich C; Pedruzo B; Radua J; Rodríguez V; Salazar de Pablo G; Pacho M; Pérez JL; Solmi M; McGuire P; Giuliano AJ; Stone WS; Murray RM; Gonzalez-Torres MA; Fusar-Poli P
    Transl Psychiatry; 2024 Jan; 14(1):15. PubMed ID: 38191534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive Function and Variability in Antipsychotic Drug-Naive Patients With First-Episode Psychosis: A Systematic Review and Meta-Analysis.
    Lee M; Cernvall M; Borg J; Plavén-Sigray P; Larsson C; Erhardt S; Sellgren CM; Fatouros-Bergman H; Cervenka S
    JAMA Psychiatry; 2024 May; 81(5):468-476. PubMed ID: 38416480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurocognitive Functioning in Individuals at Clinical High Risk for Psychosis: A Systematic Review and Meta-analysis.
    Catalan A; Salazar de Pablo G; Aymerich C; Damiani S; Sordi V; Radua J; Oliver D; McGuire P; Giuliano AJ; Stone WS; Fusar-Poli P
    JAMA Psychiatry; 2021 Jun; 78(8):859-67. PubMed ID: 34132736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Examining the variability of neurocognitive functioning in individuals at clinical high risk for psychosis: a meta-analysis.
    Catalan A; Radua J; McCutcheon R; Aymerich C; Pedruzo B; González-Torres MÁ; Baldwin H; Stone WS; Giuliano AJ; McGuire P; Fusar-Poli P
    Transl Psychiatry; 2022 May; 12(1):198. PubMed ID: 35551176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolactin and morning cortisol concentrations in antipsychotic naïve first episode psychosis: A systematic review and meta-analysis.
    Aymerich C; Pedruzo B; Pacho M; Laborda M; Herrero J; Pillinger T; McCutcheon RA; Alonso-Alconada D; Bordenave M; Martínez-Querol M; Arnaiz A; Labad J; Fusar-Poli P; González-Torres MÁ; Catalan A
    Psychoneuroendocrinology; 2023 Apr; 150():106049. PubMed ID: 36758330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sex Differences in Verbal Memory Predict Functioning Through Negative Symptoms in Early Psychosis.
    Buck G; Lavigne KM; Makowski C; Joober R; Malla A; Lepage M
    Schizophr Bull; 2020 Dec; 46(6):1587-1595. PubMed ID: 32307536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes of neurocognitive status in patients with the first-episode psychosis after 18 months of treatment-A prospective cohort study.
    Bosnjak Kuharic D; Makaric P; Kekin I; Rossini Gajsak L; Zivkovic M; Ostojic D; Silic A; Bajic Z; Lukacevic Lovrencic I; Beezhold J; Rojnic Kuzman M
    Psychiatry Res; 2021 Oct; 304():114131. PubMed ID: 34332430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropsychological Test Performance to Enhance Identification of Subjects at Clinical High Risk for Psychosis and to Be Most Promising for Predictive Algorithms for Conversion to Psychosis: A Meta-Analysis.
    Hauser M; Zhang JP; Sheridan EM; Burdick KE; Mogil R; Kane JM; Auther A; Carrión RE; Cornblatt BA; Correll CU
    J Clin Psychiatry; 2017 Jan; 78(1):e28-e40. PubMed ID: 28129494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Entire duration of active psychosis and neurocognitive performance in first-episode non-affective psychosis.
    Murillo-García N; Setién-Suero E; Pardo-de-Santayana G; Murillo-García M; Pelayo-Terán JM; Crespo-Facorro B; Ayesa-Arriola R
    Early Interv Psychiatry; 2021 Oct; 15(5):1266-1275. PubMed ID: 33244853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Social cognition and neurocognition in first-episode bipolar disorder and psychosis: The effect of negative and attenuated positive symptoms.
    Bora E; Eyuboglu MS; Cesim E; Demir M; Yalincetin B; Ermis C; Özbek Uzman S; Sut E; Demirlek C; Verim B; Baykara B; İnal N; Akdede BB
    J Affect Disord; 2024 Apr; 351():356-363. PubMed ID: 38290586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associations between age and neurocognition in individuals at clinical high risk and first-episode psychosis.
    Zhang T; Wei Y; Cui H; Tang X; Xu L; Hu Y; Tang Y; Liu H; Chen T; Li C; Wang J
    Psychiatry Res; 2023 Sep; 327():115385. PubMed ID: 37567111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meta-analysis of cognitive deficits in ultra-high risk to psychosis and first-episode psychosis: do the cognitive deficits progress over, or after, the onset of psychosis?
    Bora E; Murray RM
    Schizophr Bull; 2014 Jul; 40(4):744-55. PubMed ID: 23770934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparing cognitive clusters across first- and multiple-episode of psychosis.
    Sauvé G; Malla A; Joober R; Brodeur MB; Lepage M
    Psychiatry Res; 2018 Nov; 269():707-718. PubMed ID: 30273896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identifying neurocognitive markers for outcome prediction of global functioning in individuals with first-episode and ultra-high-risk for psychosis.
    Sawada K; Kanehara A; Sakakibara E; Eguchi S; Tada M; Satomura Y; Suga M; Koike S; Kasai K
    Psychiatry Clin Neurosci; 2017 May; 71(5):318-327. PubMed ID: 28294477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship between negative symptoms and MATRICS neurocognitive domains: A meta-analysis and systematic review.
    Au-Yeung C; Penney D; Rae J; Carling H; Lassman L; Lepage M
    Prog Neuropsychopharmacol Biol Psychiatry; 2023 Dec; 127():110833. PubMed ID: 37482283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive Training and Remediation in First-Episode Psychosis: A Literature Review.
    Miley K; Hadidi N; Kaas M; Yu F
    J Am Psychiatr Nurses Assoc; 2020; 26(6):542-554. PubMed ID: 31578909
    [No Abstract]   [Full Text] [Related]  

  • 18. Cognitive intraindividual variability, cognitive impairment and psychosocial functioning in first-episode psychosis patients.
    Sánchez-Torres AM; García de Jalón E; Gil-Berrozpe GJ; Peralta V; Cuesta MJ;
    Psychiatry Res; 2023 Oct; 328():115473. PubMed ID: 37716321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cannabis use and nonuse in patients with first-episode psychosis: A systematic review and meta-analysis of studies comparing neurocognitive functioning.
    Sánchez-Gutiérrez T; Fernandez-Castilla B; Barbeito S; González-Pinto A; Becerra-García JA; Calvo A
    Eur Psychiatry; 2020 Jan; 63(1):e6. PubMed ID: 32093788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive clusters in first-episode psychosis: Overlap with healthy controls and relationship to concurrent and prospective symptoms and functioning.
    Uren J; Cotton SM; Killackey E; Saling MM; Allott K
    Neuropsychology; 2017 Oct; 31(7):787-797. PubMed ID: 28368139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.